Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023

1
Gastrointestinal Drugs Market Global Industry
Analysis, Trends, Market Size Forecasts to 2023
2
The report on Gastrointestinal Drugs Market by
Infinium Global Research analyzes over the period
of 2017 to 2023. This report also provides
detailed qualitative and quantitative analyses of
the market dynamics, market size and future
trends in Global Gastrointestinal Drugs Market.
It will help a lot of decision makers to develop
strategies and find new opportunities in the
Global Gastrointestinal Drugs Market. The report
on global Gastrointestinal Drugs Market provides
qualitative and quantitative analysis for the
period of 2017 to 2023. According to the report
the global Gastrointestinal Drugs Market value is
projected to reach USD 59.83 billion by 2023,
growing with a CAGR of 4.5 to 5.0 from 2017 to
2023. The global Gastrointestinal Drugs Market
size was totaled 46.5 Billion in 2016. Get a
Sample Report _at_ https//www.infiniumglobalresearch
.com/Reports/MakeSampleRequest/768 Market
Insights Global gastrointestinal drugs market
experienced progressive growth over the past few
years. As per the report published by world
gastrointestinal organization in 2015, almost
35-40 of worlds population is suffering from
acute and chronic gastrointestinal complications.
This includes gastrointestinal disease and
disorder, due to change and dietary pattern,
which is predominantly responsible for global
growth of this market. Moreover, rising
prevalence of gastrointestinal disease across the
globe is equally drives global growth.
Increasing investment in research and development
activities in older to develop new drugs along
with growing awareness pertaining to availability
of these treatments have raised considerable
demand for GI drugs. Apart from this,
technological reforms in the treatment offers
superior outputs and expected to contribute
significantly in the forthcoming years. The exact
cause of GI related disorders are still unknown,
due to which cure for these disorders is not
available. This may hamper global growth of
gastrointestinal drugs market by inviting
various complications.
3

• Segments Covered
• The report segments the global Gastrointestinal
  Drugs market by drug category, by route of
  administration, by disease type, by end user and
  by region. The market size of each segment has
  been provided in terms of value (USD). Market
  segmentation based on type of drugs category
  includes Acid Neutralizers, Antidiarrheal and
  Laxatives, antiemetic, Anti-inflammatory, and
  others. Wherein acid neutralizers further sub
  segmented into antacids, H2 antagonists, and
  Proton Pump Inhibitor. On the basis of route of
  administration global market has been segmented
  into oral, parenteral, and rectal. Moreover,
  Market based on disease type includes gastro-
  esophageal reflux disorder (GERD), Inflammatory
  bowel disease, and other, whereas, end user
  segment comprises hospital pharmacies, retail
  pharmacies and other.
• Make an Enquiry _at_ https//www.infiniumglobalresear
  ch.com/Reports/MakeEnquiryRequest/768 Company
  Profiles
• Abbott Laboratories
• Allergan Plc
• AstraZeneca
• Bayer AG
• Boehringer Ingelheim GmbH
• GlaxoSmithKline Plc.
• Janssen Biotech Inc.
• Sanofi
• Takeda Pharmaceutical
• Valeant Pharmaceuticals Inc.

4

• Key topics covered
• Preface
• Executive Summary
• Global Gastrointestinal Drugs Market Overview
• Global Gastrointestinal Drugs Market IGR
  Snapshots
• Global Gastrointestinal Drugs by Drug Category
  (USD Billion) 2017 2023
• Global Gastrointestinal Drugs Market Analysis, by
  Route Of Administration (USD Billion) 2017 2023
• Global Gastrointestinal Drugs Market Analysis, by
  Disease Type (USD Billion) 2017 2023
• Global Gastrointestinal Drugs Market Analysis, by
  End User (USD Billion) 2017 2023
• Global Gastrointestinal Drugs Market Analysis, by
  Region (USD Billion) 2017 2023
• Company Profiles
• Click to View Complete Report _at_
  https//www.infiniumglobalresearch.com/healthcare_
  medical_devices/global_gastrointestinal_drugs_mar
  ket